Received Mar 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 1 | Unknown | PO / MO |
The patient experienced vomiting within first few hours after the first dose of Vivotif; Case reference number US-BN-2024-002119 is a spontaneous case initially received from other health professional via agency (reference number USBAV24-1539) on 01-Jul-2024 and concerns a female patient of unspecified age, reported as 65+. The patient's medical history and concomitant medication details were not provided. On an unspecified date, the patient took the first dose of Vivotif (batch number: unknown), at unknown dose, orally, for typhoid Immunization. On the same day, reported as within first few hours, the patient experienced vomiting. At the time of the initial report, it was unknown if the patient recovered from the event of vomiting. The reporter assessed the event of vomiting as non-serious, and causality for the event of vomiting was reported as possible. Non-significant follow up was downloaded from VAERS on 09-May-2025 included new reference number Administrative update performed within the case: Worldwide Unique Case Identification Number (WWID) updated from US-20240701-fb7dd0 to US-BAVARIAN NORDIC A/S-US-BN-2024-002119, in accordance with ICH guidance on WWID formatting.; Reporter's Comments: A female patient of unspecified age, reported as 65+, experienced vomiting, on the same day she took the first dose of Vivotif, at unknown dose, orally, for typhoid Immunization. Vomiting is listed and expected according to CCDS v8 and USPI. At this point, it was unknown if the patient recovered from the event of vomiting. The patient's medical history and concomitant medication details were not provided. Causality is assessed as related due to plausible temporal relationship, known product safety profile, lack of alternative explanation and since contributory role of suspect product cannot be excluded. The case is non-serious.; Sender's Comments: A female patient of unspecified age, reported as 65+, experienced vomiting, on the same day she took the first dose of Vivotif, at unknown dose, orally, for typhoid Immunization. Vomiting is listed and expected according to CCDS v8 and USPI. At this point, it was unknown if the patient recovered from the event of vomiting. The patient's medical history and concomitant medication details were not provided. Causality is assessed as related due to plausible temporal relationship, known product safety profile, lack of alternative explanation and since contributory role of suspect product cannot be excluded. The case is non-serious. USBAV24-1539:
Comments: None